Innovation, access and value in pharmaceuticals

Pharmaceutical markets are changing across the world, raising a number of new questions that need to be addressed. This chapter first examines trends in R&ampD and in market approvals, highlighting gaps in R&ampD investments and the focus of new treatments on small population targets. Then, it looks at current challenges faced by policy makers, from pressure to speed market access to worrying trends towards the proliferation of high-cost products, which do not always deliver value. Finally, it reviews policy responses to these challenges and possible options to go further.